AtriCure CTO acquires 636 shares via ESPP

AtriCure, Inc. Chief Technical Officer Salvatore Privitera acquired additional company stock through an employee plan.

Rhea-AI Filing Summary

AtriCure, Inc. Chief Technical Officer Salvatore Privitera acquired additional company stock through an employee plan. On June 30, 2026, he received 636 shares of common stock, bringing his direct holdings to 158,684 shares. The shares were bought under AtriCure's 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

According to the plan terms, these shares were purchased at 85% of the June 30, 2026 closing price of $27.98 per share, resulting in an effective purchase price of $23.78 per share. This is a routine compensation-related acquisition rather than an open-market trade.

Insider Trade Summary

Grant/Award: 636 shares

Grant/Award 1 txn

Insider Privitera Salvatore

Role Chief Technical Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	636	$23.78	$15K

Holdings After Transaction: Common Stock — 158,684 shares (Direct)

Footnotes (2)

1. F1. Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.
2. F2. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

Key Figures

ESPP shares acquired: 636 shares ESPP purchase price: $23.78 per share Closing price reference: $27.98 per share +2 more

5 metrics

ESPP shares acquired 636 shares Common Stock acquired on June 30, 2026 under 2018 ESPP

ESPP purchase price $23.78 per share Price for ESPP shares on June 30, 2026

Closing price reference $27.98 per share Closing price on June 30, 2026 used to set ESPP discount

Shares held after transaction 158,684 shares Direct common stock holdings following ESPP acquisition

ESPP discount rate 85% of closing price Plan terms based on June 30, 2026 closing stock price

Key Terms

2018 Employee Stock Purchase Plan, ESPP, closing price, grant, award, or other acquisition

4 terms

2018 Employee Stock Purchase Plan financial

"Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026."

ESPP financial

"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026."

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

closing price financial

"The closing price on June 30, 2026, was $27.98."

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

What did AtriCure (ATRC) CTO Salvatore Privitera report in this Form 4?

He reported acquiring 636 shares of AtriCure common stock through the company’s 2018 Employee Stock Purchase Plan. This grant increased his direct ownership to 158,684 shares and reflects routine, compensation-related participation rather than an open-market transaction.

How many AtriCure (ATRC) shares does the CTO hold after this transaction?

After the transaction, Chief Technical Officer Salvatore Privitera directly holds 158,684 shares of AtriCure common stock. This total includes the 636 shares acquired under the Employee Stock Purchase Plan for the offering period that ended on June 30, 2026.

At what price were the new AtriCure (ATRC) shares acquired under the ESPP?

The 636 shares were acquired at $23.78 per share under the Employee Stock Purchase Plan. The plan set the purchase price at 85% of AtriCure’s June 30, 2026 closing stock price, which was $27.98 per share on that trading day.

What is the AtriCure (ATRC) 2018 Employee Stock Purchase Plan mentioned in the Form 4?

It is a company program allowing eligible employees to buy AtriCure common stock at a discount. For the period ended June 30, 2026, shares were purchased at 85% of the June 30, 2026 closing price, offering employees a reduced entry price.

Was this AtriCure (ATRC) Form 4 transaction a market purchase or a compensation grant?

It was a compensation-related acquisition through the 2018 Employee Stock Purchase Plan, not an open-market purchase. The shares were obtained under preset plan terms based on 85% of the June 30, 2026 closing stock price of $27.98.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 08:58 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Privitera Salvatore

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OHIO 45040-9695

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A		636(1)	A	$23.78(2)	158,684	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

2. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

Remarks:

	/s/ Allison Walker as Attorney-in-fact for Salvatore Privitera	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)